NMRA-335140 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: BTRX 335140, BTRX-335140, CYM-53093, Navacaprant

Pipeline

Phase 3: 1

Top Sponsors

Neumora Therapeutics, Inc.1

Indications

Major Depressive Disorder1
Depression1

Huntsville, Alabama1 trial

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Neumora Investigator site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.